
Healthcare / Life Sciences · NSE
Shri Ahimsa Naturals Limited has been around since 1990, specializing in extracting and producing Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine. They also trade in other herbal extracts. Their products are widely used in industries like food & beverages, nutraceuticals, cosmetics, and pharmaceuticals, thanks to their various health benefits. The company offers Natural Caffeine, sourced from coffee and tea seeds, which is commonly found in energy drinks, soft drinks, cosmetics, and medicines. They also produce Green Coffee Bean Extract, made from unroasted coffee seeds, known for its antioxidant properties and potential weight management benefits. Shri Ahimsa Naturals exports to several countries, including the USA, Germany, South Korea, the UK, and Thailand. For the period ending September 30, 2024, they reported export revenues of ₹3,530.91 lakhs. In previous years, exports reached ₹7,463.71 lakhs in Fiscal 2023, ₹5,633.50 lakhs in Fiscal 2022, and ₹9,988.01 lakhs in their highest fiscal year. Their manufacturing facility in Jaipur, Rajasthan, follows top global standards like ISO 9001:2015, ISO 22000:2018, ISO 45001:2018, ISO 14001:2015, HACCP, and GMP, ensuring high-quality production. As of March 2025, the company had around 80 employees.
Price Band
₹113 – ₹119
Issue Size
₹73.81 Cr
Lot Size
1200 shares
GMP
+16.4%
Est. Listing
₹138.5
at current GMP
Subscribed
62.71x
overall
Open
25 Mar 2025
Close
27 Mar 2025
Allotment
28 Mar 2025
Refund
29 Mar 2025
Demat Credit
30 Mar 2025
Listing
2 Apr 2025
Last updated: 20 May 2026
Current Premium
Issue Price (Upper)
₹119
Band: ₹113 – ₹119
Estimated Listing Price
₹138.5
Upper price + GMP
Lot Size
1200 shares
Min investment ₹1,42,800
Estimated Profit / Lot
₹23,400
1200 × ₹19.5
Grey Market Premium trend
+₹19.5
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹19.5 | 16.4% | ₹138.5 |
| 30 Oct 2026 | +₹19.5 | 16.4% | ₹138.5 |
| 29 Oct 2026 | +₹18 | 14.8% | ₹137 |
GMP is unofficial market data. Not a guarantee of listing performance.
Shri Ahimsa Naturals Limited is bringing an initial public offering (IPO) in the Healthcare / Life Sciences sector with an aggregate issue size of ₹73.81 Crores. The shares are offered at a price band of ₹113 to ₹119 per equity share on NSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1200 shares (approx. ₹1,42,800 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Cameo Corporate Services Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-03-30, while un-allotted funds or UPI block mandates will be released on 2025-03-29.
The latest grey market premium for Shri Ahimsa Naturals Limited IPO is ₹19.5, which indicates an expected listing price of ₹138.5.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.